A double-blind, multicenter, randomized, parallel dose-comparison study of six regimens of 5 kD, linear peginterferon alfa-2a compared with Roferon-A in patients with chronic hepatitis C - O'Brian,C.; Pockros,P.; Reddy,R. (Antiviral Therapy, 1999)